[1]中华医学会.临床技术操作规范结核病分册. 北京:人民军医出版社,2004:24-40.[2]World Health Organization, Stop TB Partnership. The stop TB strategy:building on and enhancing DOTS to meet the TB-related Millennium development goals[DB/OL]. Geneva: WHO, 2006(2007-08-16)[2013-06-30]. http://whqlibdoc.who.int/hq/2006/WHO_HTM_STB_2006.368_eng.pdf.[3]Zignol M, van Gemert W, Falzon D, et al. Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007—2010.Bull World Health Organ, 2012, 90(2): 111-119D.[4]中华人民共和国卫生部. 全国结核病耐药性基线调查报告(2007—2008年).北京: 人民卫生出版社,2010:25-33.[5]Li X, Wang H, Jing H, et al. Population-based surveillance of extensively drug-resistant tuberculosis in Shandong Province, China. Int J Tuberc Lung Dis, 2012,16(5):612-614.[6]Liang L, Wu Q, Gao L, et al. Factors contributing to the high prevalence of multidrug-resistant tuberculosis: a study from China. Thorax, 2012, 67(7):632-638.[7]Qi YC, Ma MJ, Li DJ,et al. Multidrug-resistant and extensively drug-resistant tuberculosis in multi-ethnic region, Xinjiang Uygur Autonomous Region, China. PLoS One, 2012, 7(2): e32103.[8]Menon S, Dharmshale S, Chande C, et al. Drug resistance profiles of Mycobacterium tuberculosis isolates to first line anti-tuberculous drugs: a five years study. Lung India, 2012, 29(3): 227-231.[9]Abate D, Taye B, Abseno M, et al.Epidemiology of anti-tuberculosis drug resistance patterns and trends in tuberculosis referral hospital in Addis Ababa, Ethiopia. BMC Res Notes, 2012, 5: 462.[10]钟球,尹建军,钱明,等.广东省结核病耐药性基线调查研究. 中国防痨杂志,2011,33(7):393-399.[11]梁庆福,陈求扬,赵永,等. 福建省结核病耐药性监测结果分析.中国公共卫生,2012,28(4):420-422.[12]World Health Organization. Treatment of tuberculosis: guidelines,4th ed. Geneva:World Health Organization, 2010:29-42.[13]Prasad R. Multidrug and extensively drug-resistant tuberculosis management: Evidences and controversies. Lung India, 2012, 29(2): 154-159.[14]World Health Organization.Towards universal access to diagnosis and treatment of multidrug-resistant and extensively drug-resistant tuberculosis by 2015. Geneva: World Health Organization, 2011:18-21.[15]World Health Organization.Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. Geneva:World Health Organization, 2010:23-24.[16]Zignol M, van Gemert W, Falzon D, et al. Modernizing surveillance of antituberculosis drug resistance: from special surveys to routine testing. Clin Infect Dis, 2011,52(7):901-906.[17]World Health Organization.Guidelines for the programmatic management of drug-resistant tuberculosis(2011 update). Geneva: World Health Organization, 2011:16-20. |